Margaret H Bublitz1, Laura R Stroud. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Department of Psychiatry and Human Behavior, Brown Alpert Medical School, Coro West, Suite 314, One Hoppin Street, Providence, RI 02903, USA.
Abstract
INTRODUCTION: Maternal smoking during pregnancy (MSDP) has been associated with long-term neurobehavioral and cognitive deficits in offspring. Animal models demonstrate alterations in brain structure and function following prenatal nicotine exposure. However, few studies have assessed the relationship between MSDP and brain development in humans. Therefore, the aims of this review are (a) to synthesize findings from the small number of human studies investigating effects of MSDP on offspring brain development and (b) to outline an agenda for future research in this nascent area. METHODS: We searched MEDLINE and Psychinfo databases for human studies of MSDP and offspring brain structure and/or function. RESULTS: Eleven studies meeting our search criteria were identified; 6 studies investigated effects of MSDP on brain structure; 5 examined effects on brain function. Across studies, MSDP was associated with decreased volume/thickness of the cerebellum and corpus callosum, increased auditory brainstem responses, and lack of coordination across brain regions during information and auditory processing. CONCLUSIONS: Results from the small number of human studies revealed effects of MSDP on brain structure and function, highlighting potential neural pathways linking MSDP and offspring neurobehavioral and cognitive deficits. Given the limited amount of research in this area, we propose an agenda for future research. Gold standard studies would utilize longitudinal designs, integrated biological and maternal report measures of MSDP, and repeated measures of brain structure/function and neurobehavioral deficits across key developmental periods.
INTRODUCTION: Maternal smoking during pregnancy (MSDP) has been associated with long-term neurobehavioral and cognitive deficits in offspring. Animal models demonstrate alterations in brain structure and function following prenatal nicotine exposure. However, few studies have assessed the relationship between MSDP and brain development in humans. Therefore, the aims of this review are (a) to synthesize findings from the small number of human studies investigating effects of MSDP on offspring brain development and (b) to outline an agenda for future research in this nascent area. METHODS: We searched MEDLINE and Psychinfo databases for human studies of MSDP and offspring brain structure and/or function. RESULTS: Eleven studies meeting our search criteria were identified; 6 studies investigated effects of MSDP on brain structure; 5 examined effects on brain function. Across studies, MSDP was associated with decreased volume/thickness of the cerebellum and corpus callosum, increased auditory brainstem responses, and lack of coordination across brain regions during information and auditory processing. CONCLUSIONS: Results from the small number of human studies revealed effects of MSDP on brain structure and function, highlighting potential neural pathways linking MSDP and offspring neurobehavioral and cognitive deficits. Given the limited amount of research in this area, we propose an agenda for future research. Gold standard studies would utilize longitudinal designs, integrated biological and maternal report measures of MSDP, and repeated measures of brain structure/function and neurobehavioral deficits across key developmental periods.
Authors: Leslie K Jacobsen; Theodore A Slotkin; W Einar Mencl; Stephen J Frost; Kenneth R Pugh Journal: Neuropsychopharmacology Date: 2007-03-21 Impact factor: 7.853
Authors: Roberto Toro; Gabriel Leonard; Jacqueline V Lerner; Richard M Lerner; Michel Perron; G Bruce Pike; Louis Richer; Suzanne Veillette; Zdenka Pausova; Tomás Paus Journal: Neuropsychopharmacology Date: 2007-07-04 Impact factor: 7.853
Authors: Sabine J Roza; Bero O Verburg; Vincent W V Jaddoe; Albert Hofman; Johan P Mackenbach; Eric A P Steegers; Jacqueline C M Witteman; Frank C Verhulst; Henning Tiemeier Journal: Eur J Neurosci Date: 2007-02-12 Impact factor: 3.386
Authors: Germaine Buck Louis; Vanja Dukic; Patrick J Heagerty; Thomas A Louis; Coutney D Lynch; Louise M Ryan; Enrique F Schisterman; Ann Trumble Journal: Stat Methods Med Res Date: 2006-04 Impact factor: 3.021
Authors: Brian M D'Onofrio; Carol A Van Hulle; Irwin D Waldman; Joseph Lee Rodgers; K Paige Harden; Paul J Rathouz; Benjamin B Lahey Journal: Dev Psychopathol Date: 2008
Authors: Leslie K Jacobsen; Marina R Picciotto; Christopher J Heath; Stephen J Frost; Kristen A Tsou; Rita A Dwan; Marcel P Jackowski; Robert T Constable; W Einar Mencl Journal: J Neurosci Date: 2007-12-05 Impact factor: 6.167
Authors: Kristine Marceau; L Cinnamon Bidwell; Hollis C Karoly; Allison Schettini Evans; Alexandre A Todorov; Rohan H Palmer; Andrew C Heath; Valerie S Knopik Journal: J Abnorm Child Psychol Date: 2018-05
Authors: Kristine Marceau; Emily Rolan; Leslie D Leve; Jody M Ganiban; David Reiss; Daniel S Shaw; Misaki N Natsuaki; Helen L Egger; Jenae M Neiderhiser Journal: Dev Psychol Date: 2019-03-07
Authors: Mikael O Ekblad; Emily Rolan; Kristine Marceau; Rohan Palmer; Alexandre Todorov; Andrew C Heath; Valerie S Knopik Journal: Nicotine Tob Res Date: 2020-07-16 Impact factor: 4.244
Authors: Shawn Bauldry; Michael J Shanahan; Ross Macmillan; Richard A Miech; Jason D Boardman; Danielle O Dean; Veronica Cole Journal: Soc Sci Res Date: 2016-03-03
Authors: Sarah K Himes; Laura R Stroud; Karl B Scheidweiler; Raymond S Niaura; Marilyn A Huestis Journal: J Pediatr Date: 2012-12-01 Impact factor: 4.406